Energy drink company Monster Beverage (NASDAQ:MNST) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 4.7% year on year to $1.81
Genetic testing company Natera (NASDAQ:NTRA). reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 53% year on year to
(Bloomberg) -- For two years, Wall Street traders have minted profits simply by chasing the hottest stocks in the market regardless of price,
Voice AI recognition company SoundHound (NASDAQ:SOUN) announced better-than-expected revenue in Q4 CY2024, with sales up 101% year on year to $34.54
Apple device management company, Jamf (NASDAQ:JAMF) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 8.2% year on year to $163 million.
Programmatic advertising platform Pubmatic (NASDAQ: PUBM) missed Wall Street’s revenue expectations in Q4 CY2024 as sales only rose 1.1% year on year to
Residential solar energy company Sunrun (NASDAQ:RUN) missed Wall Street’s revenue expectations in Q4 CY2024, with sales flat year on year at $518.5
Real estate technology company Redfin (NASDAQ:RDFN) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 12% year on year to $244.3
Medical device company ICU Medical (NASDAQ:ICUI) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 7.1% year on year
Behavioral health company Acadia Healthcare (NASDAQ:ACHC) missed Wall Street’s revenue expectations in Q4 CY2024 as sales rose 4.2% year on year to
